Bacterial-associated diarrhea in the dog: A critical appraisal

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 5, 2003, Pages 1029-1060

  Marks, Stanley L ^a   Kather, Elizabeth J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; CEPHALOSPORIN; CHLORAMPHENICOL; DNA; ENROFLOXACIN; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOCHEMISTRY; CAMPYLOBACTER; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA MICROARRAY; DNA SEQUENCE; DOG DISEASE; ENTEROBACTERIACEAE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FECES CULTURE; GASTROINTESTINAL DISEASE; GENE IDENTIFICATION; GENE TARGETING; INTESTINE FLORA; MEDICAL DOCUMENTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; REVIEW; SALMONELLA; SEROLOGY; SHIGELLA; SPECIES DIFFERENTIATION; YERSINIA ENTEROCOLITICA;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CANIS FAMILIARIS; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; SALMONELLA; SHIGELLA; YERSINIA; YERSINIA ENTEROCOLITICA;

EID: 0141921472     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00091-3     Document Type: Review

References (150)

1. Greene CE. Enteric bacterial infections. In: Infectious diseases of the dog and cat. Philadelphia: WB Saunders; 1998. p. 243-5.
2. Guilford WG, Strombeck DR. Gastrointestinal tract infections, parasites, and toxicosis. In: Guilford WG, Center SA, et al, editors. Strombeck's small animal gastroenterology. Philadelphia: WB Saunders; 1996. p. 411-32.
3. Cave NJ, Marks SL, Kass PH, et al. Evaluation of a routine diagnostic fecal panel in dogs with diarrhea. J Am Vet Med Assoc 2002;221:52-9.
4. Smith L, Williams BL. Clostridium perfringens. In: Balows A, editor. The pathogenic anaerobic bacteria. Springfield (IL): Charles C. Thomas; 1984. p. 101-36.
5. Kokai-Kun JF, Songer JG, Czeczulin JR, et al. Comparison of western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens. J Clin Microbiol 1994;32:2533-9.
6. Songer JG, Meer RR. Genotyping of Clostridium perfringens by polymerase chain reaction is a useful adjunct to diagnosis of Clostridial enteric disease in animals. Anaerobe 1996;2:197-203.
7. Van Damme-Jongsten M, Wernars K, Notermans S. Cloning and sequencing of the Clostridium perfringens enterotoxin gene. Antonie van Leeuwenhoek J Microbiol 1989; 56:181-90.
8. Argenti L, Coiro R, Ciorba A. Enterite emorragica nel cane associata alla presenza di Clostridium perfringens tipo C. Summa 1987;4:279-81.
9. Meer RR, Songer JG. Multiplex polymerase chain reaction assay for genotyping Clostridium perfringens. Am J Vet Res 1997;58:702-5.
10. Marks SL, Kather EJ, Kass PH, et al. Genotypic and phenotypic characterization of Clostridium perfringens and Clostridium difficile in diarrheic and healthy dogs. J Vet Intern Med 2002;16:533-40.
11. Meer RR, Songer JG, Park DL. Human disease associated with Clostridium perfringens enterotoxin. Rev Environ Contam Toxicol 1997;150:75-94.
12. Sasaki J, Goryo M, Masatoshi A, et al. Hemorrhagic enteritis associated with Clostridium perfringens type A in a dog. J Vet Med Sci 1999;61:175-7.
13. Weese JS, Staempfli HR, Prescott JF, et al. The roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in diarrhea in dogs. J Vet Intern Med 2001;15: 374-8.
14. Garmory HS, Chanter N, French NP, et al. Occurrence of Clostridium perfringens B2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol Infect 2000;124:61-7.
15. Gibert M, Jolivet-Renaud C, Popoff MR. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 1997;203:65-73.
16. Herholz C, Miserez R, Nicolet J, et al. Prevalence of B2-toxigenic Clostridium perfringens in horses with intestinal disorders. J Clin Microbiol 1999;37:358-61.
17. Thiede S, Goethe R, Amtsberg G. Prevalence of B2 toxin gene of Clostridium perfringens type A from diarrhoeic dogs. Vet Rec 2001;149:273-4.
18. Bartlett ML, Walker HW, Ziprin R. Use of dogs as an assay for Clostridium perfringens enterotoxin. Appl Microbiol 1972;23:193-7.
19. Czeczulin JR, Collie RE, McClane BA. Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type, A, B, and C isolates of C. perfringens. Infect Immun 1996;64:3301-9.
20. Czeczulin JR, Hanna PC, McClane BA. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect Immun 1993; 61:3429-39.
21. Collie RE, McClane BA. Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases. J Clin Microbiol 1998;36:30-6.
22. Cornillot E, Saint-Joanis B, Daube G, et al. The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol Microbiol 1995;15: 639-47.
23. Miyamoto K, Chakrabarti G, Morino Y, et al. Organization of the plasmid cpe locus in Clostridium perfringens type A isolates. Infect Immun 2002;70:4261-72.
24. McClane BA. New insights into the genetics and regulation of expression of Clostridium perfringens enterotoxin. Curr Top Microbiol Immunol 1998;225:37-55.
25. McClane BA. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions. Toxicon 2001;39:1781-91.
26. Kokai-Kun JF, McClane BA. Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes. Infect Immun 1996; 64:1020-5.
27. McClane BA. An overview of Clostridium perfringens enterotoxin. Toxicon 1996;34: 1335-43.
28. Sarker MR, Singh U, McClane BA. An update on Clostridium perfringens enterotoxin. J Nat Toxins 2000;9:251-66.
29. Wieckowski EU, Kokai-Kun JF, McClane BA. Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment. Infect Immun 1998; 66:5897-905.
30. McDonel JL, Demers GW. In vivo effects of enterotoxin from Clostridium perfringens type A in the rabbit colon: binding vs. biologic activity. J Infect Dis 1982;145:490-4.
31. McDonel JL, Duncan CL. Regional localization of activity of Clostridium perfringens type A enterotoxin in the rabbit ileum, jejunum, and duodenum. J Infect Dis 1977; 136:661-6.
32. Twedt DC. Clostridium perfringens associated diarrhea in dogs. In: DeNova R, editor. Proceedings of the Eleventh Annual Veterinary Medical Forum. American College of Veterinary Internal Medicine. Madison (WI): Omni press; 1993. p. 121-5.
33. Marks SL, Melli AC, Kass PH, et al. Evaluation of methods to diagnose Clostridium perfringens-associated diarrhea in dogs. J Am Vet Med Assoc 1999;214:357-60.
34. Twedt DC. Clostridium perfringens-associated enterotoxicosis in dogs. In: Kirk RW, Bonagura JD, editors. Current veterinary therapy XI: small animal practice. Philadelphia: WB Saunders; 1992;11:602-4.
35. Berry PR, Rodhouse JC, Hughes S, et al. Evaluation of ELISA, RPLA, and Vero cell assays for detecting Clostridium perfringens enterotoxin in fecal specimens. J Clin Pathol 1988;41:458-61.
36. Modi N, Wilcox MH. Evidence for antibiotic induced Clostridium perfringens diarrhoea. J Clin Pathol 2001;54:748-51.
37. Marks SL, Kather EJ. Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs. Vet Microbiol 2003;94:39-45.
38. Kather EJ, Marks SL. Determination of the incidence of antimicrobial resistance genes in canine Clostridium perfringens. Presented at the Fourth International Conference on the Molecular Biology and Pathogenesis of the Clostridia, Woods Hole, MA. April 26-30, 2003.
39. Rood JI. Transferable tetracycline resistance in Clostridium perfringens strains of porcine origin. Can J Microbiol 1983;29:1241-6.
40. Shoemaker NB, Vlamakis H, Hayes K, et al. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 2001;67:561-8.
41. Hall JC, O'Toole E. Intestinal flora in newborn infants with description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935;9:390-402.
42. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-4.
43. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
44. Larson HE, Price AB, Honour P, et al. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978;1:1063-6.
45. Jones RL, Adney WS, Alexander AF, et al. Hemorrhagic necrotizing enterocolitis associated with Clostridium difficile infection in four foals. J Am Vet Med Assoc 1988; 193:76-9.
46. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998;49:375-90.
47. Al-Barrak A, Embil J, Dyck B, et al. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 1999;25:1-3.
48. Barbut F, Lalande V, Burghoffer B, et al. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 2002;40:2079-83.
49. Kuijper EJ, de Weerdt J, Kato H, et al. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 2001;20:528-34.
50. Riley TV, Adams JE, O'Neill GL, et al. Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiol Infect 1991;107: 659-65.
51. Struble AL, Tang YJ, Kass PH, et al. Fecal shedding of Clostridium difficile in dogs: a period prevalence survey in a veterinary medical teaching hospital. J Vet Diagn Invest 1994;6:342 7.
52. Baverud V, Gustafsson A, Franklin A, et al. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J 1997;29:279-84.
53. Brown E, Talbot GH, Axelrod P, et al. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990;11:283-90.
54. Ho M, Yang D, Wyle FA, et al. Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use. Clin Infect Dis 1996; 23(Suppl):S102-6.
55. Jones RL, Adney WS, Shideler RK. Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment. J Clin Microbiol 1987;25:1225-7.
56. Hammond GA, Johnson JL. The toxigenic element of Clostridium difficile strain VPI 10463. Microb Pathog 1995;19:203-13.
57. Just I, Fritz K, Aktories K, et al. Clostridium difficile toxin B acts on the GTP-binding protein rho. J Biol Chem 1996;269:10706-12.
58. Just I, Wilm M, Selzer J, et al. The enterotoxin from Clostridium difficile (Tox A) monoglucosylates the Rho proteins. J Biol Chem 1995;270:13932-6.
59. Lyerly DM, Saum KE, MacDonald DK, et al. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985;47:349-52.
60. Mitchell TJ, Ketley JM, Haslam SC, et al. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986;27:78-85.
61. Lima AA, Lyerly DM, Wilkins TD, et al. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun 1988;56:582-8.
62. Libby JM, Donta ST, Wilkins TD. Clostridium difficile toxin A in infants. J Infect Dis 1983;148:606.
63. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981;81:5-9.
64. Perrin J, Buogo C, Gallusser A, et al. Intestinal carriage of Clostridium difficile in neonate dogs. J Vet Med Ser B 1993;40:222-6.
65. Alfa MJ, Kabani A, Lyerly D, et al. Characterization of toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000;38:2706-14.
66. Pituch H, van den Braak N, van Leeuwen W, et al. Clonal dissemination of a toxin A-negative/toxin B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 2001;7:442-6.
67. Gulke I, Pfeifer G, Liese J, et al. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun 2001;69:6004-11.
68. Popoff MR, Rubin EJ, Gill DM, et al. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988;56:2299-306.
69. Stubbs S, Rupnik M, Gibert M, et al. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000; 186:307-12.
70. Braun M, Herholz C, Straub R, et al. Detection of the ADP-ribosyltransferase toxin gene (cdtA) and its activity in Clostridium difficile isolates from Equidae. FEMS Microbiol Lett 2000;184:29-33.
71. Perelle S, Gibert M, Bourlioux P, et al. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 1997; 65:1402-7.
72. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997;92:739-50.
73. Landry ML, Topal J, Ferguson D, et al. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples. J Clin Microbiol 2001;39:1855-8.
74. Alfa MJ, Swan B, VanDekerkhove P, et al. The diagnosis of Clostridium difficile-associated diarrhea: comparison of triage C. difficile panel, EIA for Tox A/B/ and cytotoxin assays. Diagn Microbiol Infect Dis 2002;43:257-63.
75. O'Connor D, Hynes P, Cormican M, et al. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 2001;39:2846-9.
76. Gumerlock PH, Tang YJ, Weiss JB, et al. Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol 1993;31:507-11.
77. Wolfhagen MJ, Fluit AC, Torensma R, et al. Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay. J Clin Microbiol 1994;32: 1629-33.
78. Hosie BD, Nicolson TB, Henderson DB. Campylobacter infections in normal and diarrhoeic dogs. Vet Rec 1979;105:80.
79. Malik R, Love DN. The isolation of Campylobacter jejuni/coli from pound dogs and canine patients in a veterinary hospital. Aust Vet Pract 1989;19:16-8.
80. McOrist S, Browning JW. Carriage of Campylobacter jejuni in healthy and diarrhoeic dogs and cats. Aust Vet J 1982;58:33-4.
81. Engvall EO, Brandstrom B, Gunnarsson A, et al. Validation of a polymerase chain reaction/restriction enzyme analysis method for species identification of thermophilic campylobacters isolated from domestic and wild animals. J Appl Microbiol 2002; 92:47-54.
82. Steinhauserova I, Fojtikova K, Klimes J. The incidence and PCR detection of Campylobacter upsaliensis in dogs and cats. Lett Appl Microbiol 2000;31:209-12.
83. Bourke B, Chan VL, Sherman P. Campylobacter upsaliensis: waiting in the wings. Clin Microbiol Rev 1998;11:440-9.
84. Labarca JA, Sturgeon J, Borenstein L, et al. Campylobacter upsaliensis: another pathogen for consideration in the United States. Clin Infect Dis 2002;34(Suppl):E59-60.
85. Prescott JF, Karmali MA. Attempts to transmit Campylobacter enteritis to dogs and cats. Can Med Assoc J 1978;119:1001-2.
86. Prescott JF, Barker IK, Manninen KI, et al. Campylobacter jejuni colitis in gnotobiotic dogs. Can J Comp Med 1981;45:377-83.
87. Sandstedt K, Ursing J, Walder M. Thermotolerant Campylobacter with no or weak catalase activity isolated from dogs. Curr Microbiol 1983;8:209-13.
88. Goossens H, Vlaes L, Butzler JP, et al. Campylobacter upsaliensis enteritis associated with canine infections. Lancet 1991;337:1486-7.
89. Olson P, Sandstedt K. Campylobacter in the dog: a clinical and experimental study. Vet Rec 1987;121:99-101.
90. Prescott JF, Bruin-Mosch CW. Carriage of Campylobacter jejuni in healthy and diarrheic animals. Am J Vet Res 1981;42:164-5.
91. Bruce D, Zochowsky W, Fleming GA. Campylobacter infections in cats and dogs. Vet Rec 1980;107:200-1.
92. Torre E, Tello M. Factors influencing fecal shedding of Campylobacter jejuni in dogs without diarrhea. Am J Vet Res 1993;54:260-2.
93. Fox JG, Moore R, Ackerman JI. Campylobacter jejuni-associated diarrhea in dogs. J Am Vet Med Assoc 1983;183:1430-3.
94. Skirrow MB. Campylobacter enteritis in dogs and cats: a 'new' zoonosis. Vet Res Commun 1981;5:13-9.
95. Robinson DA. Infective dose of Campylobacter jejuni in milk. BMJ (Clin Res Ed) 1981;282:1584-5.
96. Butzler JP, Skirrow MB. Campylobacter enteritis. Clin Gastroenterol 1979;8:737-65.
97. Burnens AP, Nicolet J. Detection of Campylobacter upsaliensis in diarrheic dogs and cats, using a selective medium with cefoperazone. Am J Vet Res 1992;53:48-51.
98. Aspinall ST, Wareing DR, Hayward PG, et al. A comparison of a new campylobacter selective medium (CAT) with membrane filtration for the isolation of thermophilic campylobacters including Campylobacter upsaliensis. J Appl Bacteriol 1996;80: 645-50.
99. Boosinger TR, Dillon AR. Campylobacter jejuni infections in dogs and the effect of erythromycin and tetracycline therapy on fecal shedding. J Am Anim Hosp Assoc 1992; 28:33-8.
100. Monfort JD, Donahoe JP, Stills HF, et al. Efficacies of erythromycin and chloramphenicol in extinguishing fecal shedding of Campylobacter jejuni in dogs. J Am Vet Med Assoc 1990;196:1069-72.
101. Pai CH, Gillis G, Toumanen E, et al. Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child 1983;137:286-8.
102. Davies AP, Gebhart CJ, Meric SA. Campylobacter-associated chronic diarrhea in a dog. J Am Vet Med Assoc 1984;184:469-71.
103. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25.
104. Fukata T, Naito F, Yoshida N, et al. Incidence of Salmonella infection in healthy dogs in Gifu Prefecture, Japan. J Vet Med Sci 2002;64:1079-80.
105. Kwaga JK, Adesiyun AA, Abdullahi SU, et al. Prevalence of salmonellae, shigellae and Plesiomonas shigelloides in dogs in Zaria, Nigeria. Br Vet J 1989;145:174-7.
106. Sato Y, Kuwamoto R. A case of canine salmonellosis due to Salmonella infantis. J Vet Med Sci 1999;61:71-2.
107. van Duijkeren E, Houwers D. Salmonella enteritis in dogs, not relevant? Tijdschr Diergeneeskd 2002;127:716-7.
108. Joffe DJ, Schlesinger DP. Preliminary assessment of the risk of Salmonella infection in dogs fed raw chicken diets. Can Vet J 2002;43:441-2.
109. Bäumler AJ, Tsolis RM, Heffron F. Contribution of fimbrial operons to attachment to and invasion of epithelial cell lines by Salmonella typhimurium. Infect Immun 1996;64:1862-5.
110. Francis CL, Ryan TA, Jones BD, et al. Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria. Nature 1993;364:639-42.
111. Choudhary SP, Kalimuddin M, Brasad G, et al. Observations on natural and experimental salmonellosis in dogs. J Diarrhoeal Dis Res 1985;3:149-53.
112. Day HH, James E, Heather CD. Salmonellosis in the dog. Am J Vet Res 1963;24: 156-8.
113. Wolf MK. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev 1997;10:569-84.
114. Beutin L, Geier D, Steinruck H, et al. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J Clin Microbiol 1993;31:2483-8.
115. Hammermueller J, Kruth S, Prescott J, et al. Detection of toxin genes in Escherichia coli isolated from normal dogs and dogs with diarrhea. Can J Vet Res 1995;59:265-70.
116. Starcic M, Johnson JR, Stell AL, et al. Haemolytic Escherichia coli isolated from dogs with diarrhea have characteristics of both uropathogenic and necrotoxigenic strains. Vet Microbiol 2002;85:361-77.
117. Hart CA, Batt RM, Saunders JR. Diarrhea caused by Escherichia coli. Ann Trop Paediatr 1993;13:121-31.
118. Alexander TJL. Neonatal diarrhoea in pigs. In: Gyles CL, editor. Escherichia coli in domestic animals and humans. Guilford, UK: CAB International; 1994. p. 151-70.
119. Olson O, Hedhammer A, Faris A, et al. Enterotoxigenic Escherichia coli (ETEC) and Klebsiella pneumoniae isolated from dogs with diarrhea. Vet Microbiol 1985;10: 577-89.
120. Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 1996;60:167-215.
121. Richter T, Grund S, Hellmann E. Occurrence of enterotoxic E. coli in the young dog. Description of probable pathogenicity factors. Berl Muench Tierarztl Wochenschr 1984; 97:37-43.
122. Drolet R, Fairbrother JM, Harel J, et al. Attaching and effacing and enterotoxigenic, Escherichia coli associated with enteric colibacillosis in the dog. Can J Vet Res 1994;58:87-92.
123. Beutin L, Geier D, Zimmermann S, et al. Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 1995;33:631-5.
124. Prada J, Baljer G, De Rycke J, et al. Characteristics of alpha-hemolytic strains of Escherichia coli isolated from dogs with gastroenteritis. Vet Microbiol 1991;29:59-73.
125. Turk J, Maddox C, Fales W, et al. Examination for heat-labile, heat stable, and Shiga-like toxins and for the eaeA gene in Escherichia coli isolates obtained from dogs dying with diarrhea: 122 cases (1992-1996). J Am Vet Med Assoc 1998;212:1735-6.
126. Donnenberg MS. Enteropathogenic Escherichia coli. In: Blaser MJ, Raudin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 709-26.
127. Jerse AE, Yu J, Tall BD, et al. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990;87:7839-43.
128. Penteado AS, Aidar L, Pestana de Castro AF, et al. eae-negative attaching and effacing Escherichia coli from piglets with diarrhea. Res Microbiol 2001;152:75-81.
129. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977;18:775-9.
130. O'Brian AD, LaVeck GD, Thompson MR. Production of Shigella dysenteriae type I-like cytotoxin by Escherichia coli. J Infect Dis 1982;146:763-9.
131. Calderwood SB, Acheson DWK, Keusch T, et al. Proposed new nomenclature for SLT (VT) family. ASM News 1994;62:118-9.
132. Beutin L, Montenegro M, Orskov I, et al. Close association of verotoxin (shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J Clin Microbiol 1989;27:2559-64.
133. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157 and the hemolytic-uremic syndrome. N Engl J Med 1995;333:364-8.
134. Trevena WB, Hooper S, Wray C, et al. Vero cytotoxin-producing Escherichia coli O157 associated with companion animals. Vet Rec 1996;138:400.
135. Pohl P, Oswald E, Van Muylem K, et al. Escherichia coli producing CNF1 and CNF2 cytotoxins in animals with different disorders. Vet Res 1993;24:311-5.
136. Nataro JP, Kaper JB. Diarrheogenic Escherichia coli. Clin Microbiol Rev 1998;11: 142-201.
137. Pass MA, Odedra R, Batt RM. Multiplex PCRs for identification of Escherichia coli virulence genes. J Clin Microbiol 2000;38:2001-4.
138. Jertborn M, Svennerholm AM. Enterotoxin-producing bacteria isolated from Swedish travellers with diarrhoea. Scand J Infect Dis 1991;23:473-9.
139. Olive DM. Detection of enterotoxigenic Escherichia coli after polymerase chain reaction amplification with a thermostable DNA polymerase. J Clin Microbiol 1989;27:261-5.
140. Pollard DR, Johnson WM, Lior H, et al. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 1990;28:540-5.
141. Monaghan C, Tierney U, Colleran E. Antibiotic resistance and R-factors in the fecal coliform flora of urban and rural dogs. Antimicrob Agents Chemother 1981;19:266-70.
142. Wong CS, Brandt JR. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis. JAMA 2002;288:3111-2.
143. Aranda-Michel J, Giannella RA. Acute diarrhea: a practical review. Am J Med 1999;106:670-6.
144. Baljer G, Hinsch F, Mayr B. Clinical experience with kennel-specific E. coli oral vaccines in dogs. Tierarztl Prax 1990;18:65-8.
145. Malnick H, Thomas M, Lotay H, et al. Anaerobiospirillum species isolated from humans with diarrhoea. J Clin Pathol 1983;36:1097-101.
146. Malnick H. Anaerobiospirillum thomasii sp. nov., an anaerobic spiral bacterium isolated from the feces of cats and dogs and from diarrheal feces of humans, and emendation of the genus Anaerobiospirillum. Int J Syst Bacteriol 1997;47:381-4.
147. Malnick H, Williams K, Phil-Ebosie J, et al. Description of a medium for isolating Anaerobiospirillum spp., a possible cause of zoonotic disease, from diarrheal feces and blood of humans and use of the medium in a survey of human, canine, and feline feces. J Clin Microbiol 1990;28:1380-4.
148. Fenwick SG, Madie P, Wilks CR. Duration of carriage and transmission of Yersinia enterocolitica biotype 4, serotype 0:3 in dogs. Epidemiol Infect 1994;113:471-7.
149. Hayashidani H, Kaneko K, Sakurai K, et al. Experimental infection with Yersinia enterocolitica serovar 0:8 in beagle dogs. Vet Microbiol 1995;47:71-7.
150. Tiwary BK, Prasad LB. Enteric infection in livestock and poultry caused by Salmonellae and Shigellae. Vet Rec 1972;91:510-3.